Slide One
Slide Two
Slide Three

Latest News

December 18, 2014

Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development

December 4, 2014

Protagonist Therapeutics Closes 2nd Tranche of $18 Million Series B for Advancing Development Candidate to Clinical Trials in 2015

November 5, 2014

Protagonist Therapeutics Elects Chaitan Khosla, Ph.D. to Board of Directors

Upcoming Events

17th International Congress of Mucosal Immunology (ICMI 2015)

July 14-18, 2015
Berlin, Germany

2015 Advances in IBD – Crohn’s & Colitis Foundation’s Clinical & Research Conference

December 10-12, 2015
Orlando, Florida